Trial · NCT07759687
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Speed of Attention | Baseline, 60-, 120-, 180- and 300 minutes post dose | Speed of Attention cognitive domain, calculated from reaction time (msec) performance on the following tasks: Choice Reaction Time, 4 Choice Reaction Time, Digit Vigilance, Arrow Flankers, Stroop, Rapid Visual Information Processing. |
| Secondary | Accuracy of Attention | Baseline, 60-, 120-, 180- and 300 minutes post dose | Accuracy of Attention cognitive domain, calculated from accuracy of performance (%) on the following tasks: Choice Reaction Time, 4 Choice Reaction Time, Digit Vigilance, Arrow Flankers, Stroop, Rapid Visual Information Processing. |
| Secondary | Choice Reaction Time | Baseline, 60-, 120-, 180- and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Measuring attention and vigilance. Choice Reaction Time (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance. |
| Secondary | 4 Choice Reaction Time | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention and vigilance. 4 Choice Reaction Time (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance. |
| Secondary | Digit Vigilance | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention and vigilance. Digit Vigilance (% accuracy, reaction time (msec), false alarms). With higher accuracy, lower false alarms and quicker reaction time indicating better performance. |
| Secondary | Arrow Flankers | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention and vigilance. Arrow Flankers (% accuracy, reaction time (msec). With higher accuracy and quicker reaction time indicating better performance. |
| Secondary | Stroop | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention, vigilance and executive function. Stroop Task (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance. |
| Secondary | Numeric Working Memory | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task measures working memory. Numeric Working Memory (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance. |
| Secondary | Serial Subtraction of three's | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task measures working memory and cognitive demand. Serial subtraction of three's (number of correct responses, number of error responses). With more correct responses and less error responses indicating better performance. |
| Secondary | Serial Subtraction on Seven's | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses working memory and cognitive demand. Serial subtraction of seven's (number correct responses, number error responses). With more correct responses and less errors indicating better performance. |
| Secondary | Rapid Visual Information Processing | Baseline, 60-, 120, 180-, and 300 minutes post dose | Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention, vigilance and cognitive demand. Rapid Visual Information Processing (% accuracy, reaction time (msec), false alarms). With higher accuracy, lower false alarms and quicker reaction time indicating better performance. |
| Secondary | Positive and Negative Affect Scale (PANAS) | Baseline, 60-, 120-, 180- and 300 minutes post dose | Positive and Negative Affect Scale (Watson, Clark and Tellegan, 1988). Includes 20 single-word emotion items (10 for positive affect, 10 for negative affect). Participants rate each word on a 5-point scale from 1 ("not at all") to 5 ("extremely"). It produces a Positive Affect score, and a Negative Affect score. Positive Affect score: sum of 10 positive items. Higher scores indicate higher joyful engagement. Negative Affect score: sum of the 10 negative items. Higher scores indicate higher general distress and unpleasurable moods. Scores for each sub scale range from 10 to 50. |
| Secondary | Visual Analogue Mood Sales (VAMS) | Baseline, 60-, 120, 180-, and 300 minutes post dose | Mood assessment administered using COMPASS computerised battery. Comprises of 18 x 100% lines anchored at either end by antonyms (e.g. "alert-drowsy", "calm-excited"). Participants indicate their current subjective position between the antonyms on the line. Scores are collapsed into three measures derived by factor analysis; Alertness, Stress, Tranquillity. |
| Secondary | Stress Visual Analogue Scales | Baseline, 60-, 120, 180-, and 300 minutes post dose | A mood outcome assessed as part of the COMPASS battery. Four visual analogue scales on 100% lines anchored by "Not at all" on one end and "Extremely" on the other. These include the following questions: "how stressed do you feel?", "how anxious do you feel?", "how relaxed do you feel?", and "how calm do you feel?". Data from the scales is then combined to create an average stress score, with the positive items "calm" and "relaxed" reversed. Higher scores indicate higher stress. |
| Secondary | Systolic Blood pressure | Baseline, 60-, 120-, 180-, and 300- minutes post dose. | Systolic blood pressure (mmHg) assessed following each COMPASS cognitive assessment battery. |
| Secondary | Diastolic Blood pressure | Baseline, 60-, 120-, 180-, 300- minutes post dose | Diastolic blood pressure (mmHg) assessed following each COMPASS cognitive assessment battery. |
| Secondary | Heart Rate | Baseline, 60-, 120-, 180-, 300- minutes post dose | Heart rate (BPM) assessed following each COMPASS cognitive assessment. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07759687/registered